Corporate News     11-Jun-24
Biocon appoints Interim CFO
With effect from 11 June 2024
Biocon has approved the appointment of Mukesh Kamath, Head - Business Finance R&D, as the Interim Chief Financial Officer and Key Managerial Personnel of the Company with effect from 11 June 2024 till the time new CFO is appointed by the Board.
Previous News
  Biocon acquires facility of Eywa Pharma in US for $7.7 mln
 ( Hot Pursuit - 02-Sep-23   14:59 )
  Indices trade with decent gains; realty shares rallied for 5th day
 ( Market Commentary - Mid-Session 17-May-24   12:40 )
  Biocon Ltd soars 1.22%, rises for fifth straight session
 ( Hot Pursuit - 27-Mar-24   13:00 )
  Biocon Ltd up for third consecutive session
 ( Hot Pursuit - 01-Dec-23   13:05 )
  Biocon
 ( Results - Analysis 21-Jan-22   11:16 )
  Biocon subsiary, Biocon Biologics' partner Viatris wins favourable order from U.S. court
 ( Hot Pursuit - 31-Dec-21   11:26 )
  Biocon update on Biologics License Application for MYL-1402O (bevacizumab)
 ( Corporate News - 26-Dec-20   11:14 )
  Biocon launches Abevmy in Canada
 ( Hot Pursuit - 20-May-22   08:32 )
  Biocon Biologics, Viatris get CHMP nod for Abevmy
 ( Hot Pursuit - 26-Apr-21   09:17 )
  Biocon Ltd down for fifth straight session
 ( Hot Pursuit - 07-Jun-22   13:35 )
  Biocon to declare Quarterly Result
 ( Corporate News - 11-Jan-24   11:42 )
Other Stories
  Sonu Infratech schedules EGM
  03-Jul-24   19:59
  Sakuma Exports to convene AGM
  03-Jul-24   19:59
  Time Technoplast repays commercial paper
  03-Jul-24   18:31
  Board of Aditya Vision approves stock split and listing of share on NSE
  03-Jul-24   18:24
  Pricol director resigns
  03-Jul-24   18:21
  Board of VMS Industries recommends first interim dividend
  03-Jul-24   17:49
  Lakshmi Machine Works to declare Quarterly Result
  03-Jul-24   17:44
  Modison to convene AGM
  03-Jul-24   17:43
  Sybly Industries to discuss results
  03-Jul-24   17:43
  Akme Fintrade (India) to announce Quarterly Result
  03-Jul-24   17:43
Back Top